0001851484
2022-01-01
2022-09-30
0001851484
TENKU:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightEntitlingHolderToReceiveTwotenthsOfOrdinaryShareMember
2022-01-01
2022-09-30
0001851484
TENKU:OrdinarySharesParValue0.0001PerShareMember
2022-01-01
2022-09-30
0001851484
TENKU:RightsEachRightEntitlingHolderToReceiveTwotenthsOfOneOrdinaryShareMember
2022-01-01
2022-09-30
0001851484
2022-11-30
0001851484
2022-09-30
0001851484
2021-12-31
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
us-gaap:OverAllotmentOptionMember
2022-01-01
2022-09-30
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
us-gaap:OverAllotmentOptionMember
2021-03-01
2021-12-31
0001851484
us-gaap:CommonStockMember
us-gaap:SubsequentEventMember
2022-11-27
2022-11-28
0001851484
us-gaap:CommonClassAMember
2021-12-19
2021-12-20
0001851484
us-gaap:CommonClassAMember
2021-12-20
0001851484
us-gaap:CommonClassBMember
2021-12-19
2021-12-20
0001851484
us-gaap:CommonStockMember
2021-12-19
2021-12-20
0001851484
us-gaap:CommonStockMember
2021-12-20
0001851484
2022-07-01
2022-09-30
0001851484
2021-07-01
2021-09-30
0001851484
2021-03-01
2021-09-30
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
us-gaap:OverAllotmentOptionMember
2021-03-01
2021-09-30
0001851484
us-gaap:CommonStockMember
2021-12-31
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001851484
TENKU:ShareholderReceivableMember
2021-12-31
0001851484
us-gaap:RetainedEarningsMember
2021-12-31
0001851484
us-gaap:CommonStockMember
2022-03-31
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001851484
TENKU:ShareholderReceivableMember
2022-03-31
0001851484
us-gaap:RetainedEarningsMember
2022-03-31
0001851484
2022-03-31
0001851484
us-gaap:CommonStockMember
2022-06-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001851484
TENKU:ShareholderReceivableMember
2022-06-30
0001851484
us-gaap:RetainedEarningsMember
2022-06-30
0001851484
2022-06-30
0001851484
us-gaap:CommonStockMember
2021-02-28
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-02-28
0001851484
TENKU:ShareholderReceivableMember
2021-02-28
0001851484
us-gaap:RetainedEarningsMember
2021-02-28
0001851484
2021-02-28
0001851484
us-gaap:CommonStockMember
2021-03-31
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0001851484
TENKU:ShareholderReceivableMember
2021-03-31
0001851484
us-gaap:RetainedEarningsMember
2021-03-31
0001851484
2021-03-31
0001851484
us-gaap:CommonStockMember
2021-06-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0001851484
TENKU:ShareholderReceivableMember
2021-06-30
0001851484
us-gaap:RetainedEarningsMember
2021-06-30
0001851484
2021-06-30
0001851484
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001851484
TENKU:ShareholderReceivableMember
2022-01-01
2022-03-31
0001851484
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001851484
2022-01-01
2022-03-31
0001851484
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001851484
TENKU:ShareholderReceivableMember
2022-04-01
2022-06-30
0001851484
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001851484
2022-04-01
2022-06-30
0001851484
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001851484
TENKU:ShareholderReceivableMember
2022-07-01
2022-09-30
0001851484
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001851484
us-gaap:CommonStockMember
2021-03-01
2021-03-31
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-03-01
2021-03-31
0001851484
TENKU:ShareholderReceivableMember
2021-03-01
2021-03-31
0001851484
us-gaap:RetainedEarningsMember
2021-03-01
2021-03-31
0001851484
2021-03-01
2021-03-31
0001851484
us-gaap:CommonStockMember
2021-04-01
2021-06-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-04-01
2021-06-30
0001851484
TENKU:ShareholderReceivableMember
2021-04-01
2021-06-30
0001851484
us-gaap:RetainedEarningsMember
2021-04-01
2021-06-30
0001851484
2021-04-01
2021-06-30
0001851484
us-gaap:CommonStockMember
2021-07-01
2021-09-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-07-01
2021-09-30
0001851484
TENKU:ShareholderReceivableMember
2021-07-01
2021-09-30
0001851484
us-gaap:RetainedEarningsMember
2021-07-01
2021-09-30
0001851484
us-gaap:CommonStockMember
2022-09-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001851484
TENKU:ShareholderReceivableMember
2022-09-30
0001851484
us-gaap:RetainedEarningsMember
2022-09-30
0001851484
us-gaap:CommonStockMember
2021-09-30
0001851484
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0001851484
TENKU:ShareholderReceivableMember
2021-09-30
0001851484
us-gaap:RetainedEarningsMember
2021-09-30
0001851484
2021-09-30
0001851484
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-17
2022-10-18
0001851484
TENKU:UnderwriterMember
us-gaap:SubsequentEventMember
us-gaap:OverAllotmentOptionMember
2022-10-17
2022-10-18
0001851484
us-gaap:CommonStockMember
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-17
2022-10-18
0001851484
TENKU:UnderwriterMember
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-17
2022-10-18
0001851484
us-gaap:SubsequentEventMember
us-gaap:PrivatePlacementMember
2022-10-17
2022-10-18
0001851484
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-18
0001851484
us-gaap:SubsequentEventMember
2022-10-17
2022-10-18
0001851484
us-gaap:SubsequentEventMember
us-gaap:PrivatePlacementMember
2022-10-18
0001851484
us-gaap:SubsequentEventMember
TENKU:PublicShareholdersMember
2022-10-18
0001851484
srt:MinimumMember
us-gaap:SubsequentEventMember
2022-10-18
0001851484
srt:MaximumMember
us-gaap:SubsequentEventMember
2022-10-18
0001851484
us-gaap:IPOMember
2022-09-30
0001851484
us-gaap:IPOMember
2021-12-31
0001851484
TENKU:UnderwriterMember
us-gaap:CommonStockMember
us-gaap:OverAllotmentOptionMember
2022-01-01
2022-09-30
0001851484
us-gaap:IPOMember
2022-01-01
2022-09-30
0001851484
TENKU:UnderwriterMember
us-gaap:OverAllotmentOptionMember
2022-01-01
2022-09-30
0001851484
TENKU:UnderwriterMember
us-gaap:OverAllotmentOptionMember
2022-09-30
0001851484
us-gaap:PrivatePlacementMember
2022-01-01
2022-09-30
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
2021-12-19
2021-12-20
0001851484
2021-12-20
0001851484
TENKU:UnderwritersMember
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-17
2022-10-18
0001851484
TENKU:UnderwritersMember
us-gaap:SubsequentEventMember
us-gaap:OverAllotmentOptionMember
2022-11-27
2022-11-28
0001851484
TENKU:UnderwritersMember
us-gaap:SubsequentEventMember
us-gaap:IPOMember
2022-10-18
0001851484
TENKU:UnderwritersMember
us-gaap:SubsequentEventMember
2022-10-17
2022-10-18
0001851484
TENKU:UnderwritersMember
us-gaap:SubsequentEventMember
us-gaap:OverAllotmentOptionMember
2022-10-17
2022-10-18
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
us-gaap:CommonStockMember
us-gaap:OverAllotmentOptionMember
2022-01-01
2022-09-30
0001851484
srt:MaximumMember
TENKU:UnderwriterMember
us-gaap:CommonStockMember
us-gaap:OverAllotmentOptionMember
2021-03-01
2021-12-31
0001851484
TENKU:UnderwriterMember
us-gaap:CommonStockMember
us-gaap:SubsequentEventMember
us-gaap:OverAllotmentOptionMember
2022-10-17
2022-10-18
0001851484
us-gaap:CommonStockMember
2022-01-01
2022-09-30
iso4217:USD
shares
iso4217:USD
shares
pure
0001851484
false
Q3
--12-31
10-Q
true
2022-09-30
2022
false
001-41534
TenX Keane Acquisition
E9
420 Lexington Ave
Suite 2446
New York
NY
10170
(347)
627-0058
Yes
Yes
Non-accelerated Filer
true
true
false
true
Units, each consisting of one ordinary share, $0.0001 par value, and one right entitling the holder to receive two-tenths of an ordinary share
TENKU
NASDAQ
Ordinary shares, par value $0.0001 per share
TENK
NASDAQ
Rights, each right entitling the holder to receive two-tenths of one ordinary share
TENKR
NASDAQ
8941000
256745
126422
256745
126422
73694
5848
193164
130687
266858
136535
0.0001
0.0001
1000000
1000000
0
0
0
0
0.0001
0.0001
150000000
150000000
1725000
1725000
1725000
1725000
173
173
173
173
-25000
-25000
24827
24827
-10113
-10113
-10113
-10113
256745
126422
225000
225000
150000
287500
1725000
150000000
0.0001
1437500
1437500
0.0001
10000000
10113
-10113
1500000
1500000
1500000
1500000
-0.00
-0.00
-0.00
-0.01
225000
187500
287500
1725000
150000000
0.0001
1437500
1437500
0.0001
10000000
1725000
173
24827
-25000
-10113
-10113
1725000
173
24827
-25000
-10113
-10113
1725000
173
24827
-25000
-10113
-10113
1725000
173
24827
-25000
-19113
-10113
1437500
144
24856
-25000
1437500
144
24856
-25000
-9389
-9389
1437500
144
24856
-25000
-9389
-9389
-724
-724
1437500
144
24856
-25000
-10113
-10113
1437500
144
24856
-25000
-10113
-10113
1437500
144
24856
-25000
-10113
-10113
225000
287500
1725000
150000000
0.0001
1437500
1437500
0.0001
10000000
187500
-10113
10113
67846
62477
86913
<p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zrH9itjOwcsj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 — <span id="xdx_826_zdm7E8ylpy29">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TenX
Keane Acquisition (the “Company”) was incorporated in the Cayman Islands on March 1, 2021. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the “Business Combination”).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not limited to a particular industry or sector for purposes of consummating an Initial Business Combination. The Company is
an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging
growth companies.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2022, the Company had not commenced any operations. All activity for the period from March 1, 2021 (inception) through
September 30, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”),
which is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed
Public Offering. The Company has selected December 31 as its fiscal year end.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective
on October 13, 2022. On October 18, 2022, the Company consummated the Initial Public Offering of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSAueCQIjz9h" title="Stock issued during period, shares">6,600,000</span> units, including <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zVL3Pd29MLT1" title="Stock issued during period, shares">600,000</span> additional
units issued pursuant to the partial exercise by the underwriter of its over-allotment option, (“Units” and, with respect
to the common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAnqOn9Vf5C" title="Proceeds from initial public offering, costs">66,000,000</span>,
which is described in Note 3.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the “Private
Placement”) of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zp96rLVZ1sBl" title="Number of units issued">394,000</span> Units (the “Placement Units”), to the 10XYZ Holdings LP (the “Sponsor”) at a price
of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zM2vajY2MPN3" title="Price per share">10.00</span> per Placement Unit, generating total proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z6vn877dl7da" title="Proceeds from private placement">3,940,000</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 18, 2022, transaction costs amounted to $<span id="xdx_908_eus-gaap--PaymentsOfStockIssuanceCosts_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNkd5PSFJEle" title="Transaction costs">4,859,330</span> consisting of $<span id="xdx_903_eus-gaap--PaymentsForUnderwritingExpense_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZ7bVIKhNvE8" title="Cash underwriting fees">1,320,000</span> of cash underwriting fees, non-cash underwriting
fees of $<span id="xdx_905_ecustom--PaymentsForNonCashUnderwritingExpense_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zcCMtXKpRqL6" title="Non-cash underwriting fees">2,922,480</span> represented by the fair value of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zySwGFtYwofa" title="Stock issued during period shares new issues">297,000</span> shares issued to the underwriter and $<span id="xdx_90F_ecustom--OtherOfferingCosts_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPmIXEHeNAv9" title="Other offering costs">616,850</span> of other offering costs. These
costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon
completion of the Initial Public Offering.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on October 18, 2022, an amount of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zTQE8WiGCa4g" title="Proceeds from initial public offering, costs">67,320,000</span> ($<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHEPU6afZvV9" title="Price per share">10.20</span> per Unit) from the net proceeds of the
sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 4) was placed in the Trust Account. The
funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the
Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any
open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii)
the distribution of the Trust Account, as described below.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more
operating businesses or assets with a fair market value equal to at least <span id="xdx_906_ecustom--ConditionForFutureBusinessCombinationUseOfProceedsPercentage_dp_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkkMo46hxNqf" title="Condition for future business combination use of proceeds percentage">80</span>% of the assets held in the Trust Account (as defined below)
(excluding the taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires <span id="xdx_90C_ecustom--ConditionForFutureBusinessCombinationThresholdPercentageOwnership_dp_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0qdtBAxyIfj" title="Condition for future business combination threshold percentage ownership">50</span>% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will
be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering, management has agreed that $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zRYsHbOLLiMg" title="Price per share">10.00</span>
per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust
account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as
a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act,
as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds
in the Trust Account to the Company’s shareholders, as described below.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicShareholdersMember_zAECG6jUNoN8" title="Price per share">10.00</span> per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s
liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection
with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”).
In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity
instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common
stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding
instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity will be the allocated proceeds
determined in accordance with ASC 470-20. The ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument
will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date
of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption
date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of
the instrument to equal the redemption value at the end of each reporting period. The Company has elected to immediate fair value recognition.
The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional
paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $<span id="xdx_902_ecustom--NetTangibleAssetsUponRedemptionOfBusinessCombinations_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zvvBu37qrQHf" title="Net tangible assets upon redemption of business combinations">5,000,001</span>, the Public Shares
are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $<span id="xdx_902_ecustom--NetTangibleAssetsUponRedemptionOfBusinessCombinations_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_z8Mwj7nf7bt" title="Net tangible assets upon redemption of business combinations">5,000,001</span> (so that it does
not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that
may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination,
the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving
a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does
not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum
and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the
“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement
with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Proposed
Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public
Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant
to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder
is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of <span id="xdx_90E_ecustom--RedemptionLimitPercentageWithoutPriorWrittenConsent_dp_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPVR9vYXfrg3" title="Redemption limit percentage without prior written consent">15</span>% of the Public
Shares without the Company’s prior written consent.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association
(i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial
Business Combination or to redeem <span id="xdx_900_ecustom--PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_dp_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvRXS8fPlQc5" title="Percentage obligation to redeem public shares if entity does not complete business combination">100</span>% of the Public Shares if the Company does not complete a Business Combination within the Combination
Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business
combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval
of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public
Shares.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will have until 9 months (or 18 months if the Company extends the period) from the closing of the Proposed Public Offering to
consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination
within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem <span id="xdx_90F_ecustom--PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_dp_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGAjqQuk6LCj" title="Percentage obligation to redeem public shares if entity does not complete business combination">100</span>% of the Public Shares, at a per-share price, payable in cash, equal
to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our
taxes, if any (less up to $<span id="xdx_900_ecustom--MaximumAllowedDissolutionExpenses_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwweAlYrdyo9" title="Maximum allowed dissolution expenses">100,000</span> of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public
Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive
further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval
of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the
Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will
receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its
respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account
if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible
that the per share value of the assets remaining available for distribution will be less than the Proposed Public Offering price per
Unit ($<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztHGtOPYWPjd" title="Price per share">10.00</span>).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent
any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amount of funds in the Trust Account to below the lesser of (1) $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zVemf3XVmhO4" title="Price per share">10.00</span> per Public Share and (2) the actual amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_z01wbrshjT0j" title="Price per share">10.00</span> per Public Share, due to reductions
in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any
claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the
Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will
seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target
businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest
or claim of any kind in or to monies held in the Trust Account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern Consideration</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)
2014-15, <i>“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”</i> management
believes that the funds which the Company has available following the completion of the Initial Public Offering will enable it to sustain
operations for a period of at least one-year from the issuance date of this financial statement. However, management has determined that
the combination period is less than one year from the date of the issuance of the financial statements. There is no assurance that the
Company’s plans to consummate a business combination will be successful within the combination period. As a result, there is substantial
doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are
issued or are available to be issued. The financial statements do not include any adjustments that might result from the outcome of the
uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Public Offering and/or
search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
6600000
600000
66000000
394000
10.00
3940000
4859330
1320000
2922480
297000
616850
67320000
10.20
0.80
0.50
10.00
10.00
5000001
5000001
0.15
1
1
100000
10.00
10.00
10.00
<p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zNVWLcrg0IO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 — <span id="xdx_828_z96AWUP94od7">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFR3dxIc5WX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5fyUGb7zpl6">Basis
of Presentation</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“US GAAP”).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of the Company’s management, the unaudited condensed financial statements as of September 30, 2022 include all adjustments,
which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September
30, 2022 and its results of operations and cash flows for the nine months ended September 30, 2022. The results of operations for the
nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full fiscal year ending December
31, 2022.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zMvxDmDXB00d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zoxxHVMg8Dz4">Emerging
Growth Company</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities
Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_84E_eus-gaap--UseOfEstimates_zSXdKT2Zqgy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z5Ae0gxPLaAa">Use
of Estimates</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zYNz6QrB7JA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zFyJjhoScHwf">Deferred
Offering Costs</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the
underwriting discounts and commissions, will be charged to additional paid in capital upon completion of the Initial Public Offering.
As of September 30, 2022 and December 31, 2021 the Company had deferred offering costs of $<span id="xdx_90E_eus-gaap--DeferredOfferingCosts_iI_c20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxvVPId0bWod" title="Deferred offering costs">256,745</span>, and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxm0Vc49HOUg" title="Deferred offering costs">126,422</span>, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zHS6lRmysQF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zs8sdz5gj1vl">Income
Taxes</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to
unrecognized tax benefits as income tax expense. There were <span id="xdx_908_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20220930_zal8ERc7aCD8" title="Unrecognized tax benefits"><span id="xdx_905_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20210930_z0Hx1wOo6Cgb" title="Unrecognized tax benefits"><span id="xdx_904_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zyXPb6t75Bk4" title="Unrecognized tax benefits">no</span></span></span>
unrecognized tax benefits and <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20220930_z1bJCkCHDuEf" title="Amounts accrued for interest and penalties"><span id="xdx_907_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20210930_zFjelskzmGa8" title="Amounts accrued for interest and penalties"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20211231_zvJ2T0eV3g1i" title="Amounts accrued for interest and penalties">no</span></span></span>
amounts accrued for interest and penalties as of September 30, 2022, September 30, 2021 and December 31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its
position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zELTkhWzO1gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zOu9gv35PaCl">Net
Loss per Ordinary Share</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period,
excluding shares of ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z82Fkr2xUZ23" title="Weighted average shares">225,000</span>
founder shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). At September
30, 2022 and September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the period presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_z752mHlrEo4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpddHD43gLRi">Derivative
Financial Instruments</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>.” For derivative financial instruments that
are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding
financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zRSgMxTdLot8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zaTFjKGbyvuh">Concentration
of Credit Risk</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zkkQPbbJSWFh" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on this account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zJWyp1fPiIV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrJnoBaMOwUg">Fair
Value of Financial Instruments</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “<i>Fair Value
Measurement</i>,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9XHsPjBc5m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_ziJL4PLFmFH5">Recent
Accounting Standards</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “<i>Debt — Debt with
Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity
(Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>,”
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also
removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and
it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022.
Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company’s financial statements.</span></p>
<p id="xdx_85E_zvd09mSVLs1k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zFR3dxIc5WX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5fyUGb7zpl6">Basis
of Presentation</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“US GAAP”).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of the Company’s management, the unaudited condensed financial statements as of September 30, 2022 include all adjustments,
which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of September
30, 2022 and its results of operations and cash flows for the nine months ended September 30, 2022. The results of operations for the
nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full fiscal year ending December
31, 2022.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zMvxDmDXB00d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zoxxHVMg8Dz4">Emerging
Growth Company</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities
Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_84E_eus-gaap--UseOfEstimates_zSXdKT2Zqgy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z5Ae0gxPLaAa">Use
of Estimates</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_840_eus-gaap--DeferredChargesPolicyTextBlock_zYNz6QrB7JA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zFyJjhoScHwf">Deferred
Offering Costs</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the
underwriting discounts and commissions, will be charged to additional paid in capital upon completion of the Initial Public Offering.
As of September 30, 2022 and December 31, 2021 the Company had deferred offering costs of $<span id="xdx_90E_eus-gaap--DeferredOfferingCosts_iI_c20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxvVPId0bWod" title="Deferred offering costs">256,745</span>, and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxm0Vc49HOUg" title="Deferred offering costs">126,422</span>, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
256745
126422
<p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zHS6lRmysQF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zs8sdz5gj1vl">Income
Taxes</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to
unrecognized tax benefits as income tax expense. There were <span id="xdx_908_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20220930_zal8ERc7aCD8" title="Unrecognized tax benefits"><span id="xdx_905_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20210930_z0Hx1wOo6Cgb" title="Unrecognized tax benefits"><span id="xdx_904_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zyXPb6t75Bk4" title="Unrecognized tax benefits">no</span></span></span>
unrecognized tax benefits and <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20220930_z1bJCkCHDuEf" title="Amounts accrued for interest and penalties"><span id="xdx_907_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20210930_zFjelskzmGa8" title="Amounts accrued for interest and penalties"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20211231_zvJ2T0eV3g1i" title="Amounts accrued for interest and penalties">no</span></span></span>
amounts accrued for interest and penalties as of September 30, 2022, September 30, 2021 and December 31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its
position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
0
0
0
0
0
0
<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zELTkhWzO1gc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zOu9gv35PaCl">Net
Loss per Ordinary Share</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share is computed by dividing net loss by the weighted average number of shares of ordinary shares outstanding during the period,
excluding shares of ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z82Fkr2xUZ23" title="Weighted average shares">225,000</span>
founder shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). At September
30, 2022 and September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the period presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
225000
<p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_z752mHlrEo4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpddHD43gLRi">Derivative
Financial Instruments</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>.” For derivative financial instruments that
are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding
financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zRSgMxTdLot8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zaTFjKGbyvuh">Concentration
of Credit Risk</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zkkQPbbJSWFh" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on this account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
250000
<p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zJWyp1fPiIV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrJnoBaMOwUg">Fair
Value of Financial Instruments</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “<i>Fair Value
Measurement</i>,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9XHsPjBc5m3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_ziJL4PLFmFH5">Recent
Accounting Standards</span></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “<i>Debt — Debt with
Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity
(Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>,”
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also
removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and
it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022.
Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company’s financial statements.</span></p>
<p id="xdx_803_ecustom--InitialPublicOfferingTextBlock_zdelqZXqH6dh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 — <span id="xdx_829_zwlQcaMucpgk">INITIAL PUBLIC OFFERING</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zcY7XY7c3mnh" title="Sale of stock shares issued in transaction">6,600,000</span>
Units, including <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_z9EttOIdacI3" title="Sale of stock shares issued in transaction">600,000</span>
additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zZzgwMtpZOUa" title="Price per share">10.00</span>
per Unit. <span id="xdx_905_eus-gaap--CommonStockConversionBasis_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF7MWC3ECffh" title="Ordinary share conversion basis">Each
Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation
of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the
holder to one share of ordinary shares</span> (see Note 7).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
6600000
600000
10.00
Each
Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation
of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the
holder to one share of ordinary shares
<p id="xdx_801_ecustom--PrivatePlacementTextBlock_zz8LjznMCEzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 — <span id="xdx_824_z7HBBOPjrS0j">PRIVATE PLACEMENTS</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private sale of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoh6yuKdB7h2" title="Number of private units issued">394,000</span> Private Placement Units. <span id="xdx_906_eus-gaap--CommonStockConversionBasis_c20220101__20220930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z11YcnWqkkQf" title="Ordinary share conversion basis">Each Unit
consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the
Company’s initial business combination one right (“Public Right”)</span>. The proceeds from the sale of the Private Placement
Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business
Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be
used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units and Private
Rights (including the ordinary shares issuable upon exercise of the Private Rights) will not be transferable, assignable or salable until
30 days after the completion of an Initial Business Combination, subject to certain exceptions.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
394000
Each Unit
consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the
Company’s initial business combination one right (“Public Right”)
<p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zv9OREgtSU1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 — <span id="xdx_822_zbmqjKGWSA0k">RELATED PARTIES</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, the Sponsor received <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210323__20210324__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z496E6GfUKsa" title="Stock issued during period shares new issues">1,437,500</span> of the Company’s ordinary shares (the “Founder Shares”) in exchange
for $<span id="xdx_907_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20210323__20210324__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__us-gaap--AwardTypeAxis__custom--ToBePaidLaterMember_za8psT2l6E3c" title="Exchange amounts transaction">25,000</span> to be paid at a later date. On December 20, 2021, the board of directors of the Company and our sponsor, as sole shareholder
of the Company, approved, through a special resolution, the following share capital changes:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the authorized but unissued <span id="xdx_90F_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcghjQ2HONRk" title="Common stock, authorized but unissued">150,000,000</span> Class A ordinary shares were cancelled and re-designated as ordinary shares of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6wfNqWlzPul" title="Common stock, par value">0.0001</span>
par value each;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z2AGgtB5LGp2" title="Stock issued during period shares new issues">1,437,500</span> Class B ordinary shares in issue were exchanged in consideration for the issuance of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211219__20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW6Agg1LWkrj" title="Ordinary shares exchanged in consideration for issuance">1,437,500</span> ordinary shares of
$<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCU3GipMcFIl" title="Shares issued price per share">0.0001</span> par value each; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of the above steps, the authorized but unissued <span id="xdx_90E_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhd1IBrkG3ra" title="Common stock, authorized but unissued">10,000,000</span> Class B ordinary shares were cancelled.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 20, 2021, subsequent to the above share exchange the Company issued an additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211219__20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z1VhMJOkuln3">287,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares to our Sponsor for no additional
consideration, resulting in our Sponsor holding an aggregate of <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z8qTs31Dr20c">1,725,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares (the founder shares). The issuance
was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively.
The founder shares include an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember__srt--RangeAxis__srt--MaximumMember_ztzpeSqHWh97">225,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares subject to forfeiture to the
extent that the underwriters’ over-allotment is not exercised in full or in part. On October 18, 2022, the underwriter partially
exercised the over-allotment and as such, as of November 28, 2022, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20221127__20221128__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGlrIcMLXif2" title="Ordinary shares forfeiture">150,000</span> ordinary shares are not subject to forfeiture.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported
sale price of the ordinary shares equals or exceeds $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20211220_zy3mPuL56WVl" title="Sale of stock price per share">12.00</span> per share (as adjusted for stock splits, stock capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business
Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction
that results in all of the Public Shareholders having the right to exchange their shares of ordinary shares for cash, securities or other
property.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note — Related Party</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210317__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_z0zPYc1cajlf" title="Aggregate principal amount">300,000</span>. The Promissory Note is non-interest bearing and payable on the
earlier of (i) September 30, 2022 or (ii) the consummation of the Proposed Public Offering. As of September 30, 2022 and December 31,
2021, there were no amounts outstanding under the Promissory Note.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances
from Related Party</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor paid certain formation and operating costs on behalf of the Company. These advances are due on demand and non-interest bearing.
As of September 30, 2022 and December 31, 2021, the amount due to the Sponsor was $<span id="xdx_909_eus-gaap--DueToRelatedPartiesCurrent_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z9IPdoc5fAx2" title="Due to related parties, current">193,164</span> and $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zYkXZieVqVkg" title="Due to related parties, current">130,687</span>, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Services Agreement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $<span id="xdx_90B_eus-gaap--SponsorFees_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zkn4WtkVkIol" title="Sponsor fees">10,000</span> per month for office
space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s
liquidation, the Company will cease paying these monthly fees.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related
Party Loans</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working
Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a
Business Combination, without interest, or, at the lender’s discretion, up to $<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_c20220101__20220930__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zzdJKhqRN6Vb" title="Repayments of related party debt">1,500,000</span> of the notes may be converted into units,
at the price of $<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20220930_zkcDMxRW3Ofj" title="Share price">10.00</span> per unit at the option of the lender. Such units would be identical to the Private Placement Units In the event
that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working
Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2022 and
December 31, 2021, there were <span id="xdx_904_ecustom--WorkingCapitalLoans_iI_do_c20220930_z0Uert9GWOc5" title="Working capital loans"><span id="xdx_90C_ecustom--WorkingCapitalLoans_iI_do_c20211231_zGyshTCeAQrk" title="Working capital loans">no</span></span> amounts outstanding under the Working Capital Loans.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
1437500
25000
150000000
0.0001
1437500
1437500
0.0001
10000000
287500
1725000
225000
150000
12.00
300000
193164
130687
10000
1500000
10.00
0
0
<p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zwZsw0mzIJJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 — <span id="xdx_82F_zlfFreDt7pHd">COMMITMENTS AND CONTINGENCIES</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and any
shares of ordinary shares issuable upon the exercise of the Private Placement Right) will be entitled to registration rights pursuant
to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to
register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form
registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration
rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company
to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides
that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until
the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBTcs9cnMji" title="Stock issued during period shares new issues">900,000</span> additional Units
to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As of November
28, 2022, the underwriter had partially exercised the over-allotment in the amount of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20221127__20221128__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZFCCq4Lfoyb" title="Stock issued during period shares option exercised">600,000</span> Units.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are entitled to a cash underwriting discount of $<span id="xdx_906_ecustom--UnderwritingCommitmentsPerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVPQJurOfu41" title="Aggregate underwriting discount">0.20</span> per Unit payable upon the closing of the Initial Public Offering.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are also entitled to <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoOyLTDi5Azc" title="Number of shares issued to underwriters">270,000</span> ordinary shares (<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zR2efVRk6704" title="Number of shares issued to underwriters">310,500</span> if the over-allotment option is exercised in full) as part of its
underwriting fee. Due to the partial exercise, the shares granted at October 18, 2022 were <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221017__20221018__srt--TitleOfIndividualAxis__custom--UnderwritersMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqwEKlWIeOlj" title="Number of shares granted">297,000</span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
900000
600000
0.20
270000
310500
297000
<p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zVcF31mXgbw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 — <span id="xdx_821_zQoffA6P9725">SHAREHOLDERS’ EQUITY</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Shares</i></b> — The Company is authorized to issue <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220930_zQvtyZIdOqWf" title="Preferred stock, shares authorized">1,000,000</span> preferred shares with a par value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220930_zW4AczDq3pCa" title="Preferred stock, par or stated value per share">0.0001</span> per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors.
As of September 30, 2022 and December 31, 2021, there were <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20220930_zYVT8YiWiWZa" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20211231_zuBl8cAez9e4" title="Preferred stock, shares outstanding">no</span></span> shares of preferred shares issued or outstanding.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b> — The Company is authorized to issue <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdr2jXT4qhng" title="Common stock, stock authorized">150,000,000</span> ordinary shares with a par value of $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zU9UHYbwpBL6" title="Common stock, par value">0.0001</span> per share. Holders
of ordinary shares are entitled to one vote for each share.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2022 and December 31, 2021, there were <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWSWz7WhYiui" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3IoixTLvYbj" title="Common stock, shares outstanding"><span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zymXOuhwNUDc" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVGHy31ygGa7" title="Common stock, shares outstanding">1,725,000</span></span></span></span> ordinary shares issued and outstanding, of which an aggregate of up
to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zYsycNAcwuPh" title="Common stock shares subject to forfeiture"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20210301__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zfpEgzkqpVY7" title="Common stock shares subject to forfeiture">225,000</span></span> ordinary shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised
in full or in part so that the number of Founder Shares will equal <span id="xdx_903_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSvWOGcStTh4" title="Percentage of issued and outstanding shares"><span id="xdx_90A_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20210301__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zoonpT3A4IZ7" title="Percentage of issued and outstanding shares">19%</span></span> of the Company’s issued and outstanding ordinary shares
after the Initial Public Offering (excluding private placement shares) or approximately <span id="xdx_90E_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ziDUpyJFo7z7" title="Percentage of issued and outstanding shares">23.0%</span> (including private placement shares). The
underwriter partially exercised the over-allotment and as such <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20221017__20221018__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zsz3ECKQCk3l" title="Common stock shares not subject to forfeiture">150,000</span> ordinary shares are not subject to forfeiture as of October 18,
2022.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the founder shares will have the right to vote on the election of directors prior to the Business Combination. Holders of
ordinary shares and holders of founder shares will vote together as a single class on all matters submitted to a vote of our shareholders
except as otherwise required by law. In connection with our initial business combination, we may enter into a shareholders’ agreement
or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements
that differ from those in effect upon completion of this offering.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case that additional shares of ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts
issued in the Proposed Public Offering and relate to the closing of a Business Combination, the ratio at which founder shares will be
adjusted (unless the holders of a majority of the then-outstanding shares of founder shares agree to waive such adjustment with respect
to any such issuance or deemed issuance) so that the number of founder shares will equal, in the aggregate, <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20220101__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7dowMBUV0Rh" title="Outstanding percentage">19%</span> of the sum of the total
number of all shares of ordinary shares outstanding upon the completion of Proposed Public Offering plus all shares of ordinary shares
and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of ordinary
shares redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any
seller of an interest in the target to us in a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
</i></b>- Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically
receive two-tenths (2/10) of one ordinary share upon consummation of the initial business combination. The Company will not issue fractional
shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise
addressed in accordance with the applicable provisions of Cayman law.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
1000000
0.0001
0
0
150000000
0.0001
1725000
1725000
1725000
1725000
225000
225000
0.19
0.19
0.230
150000
0.19
<p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zvkQcFacVlBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 — <span id="xdx_82C_zhYDAcZn2Nra">SUBSEQUENT EVENTS</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, except as noted below, the Company did not identify any subsequent events that would have required
adjustment or disclosure in the financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 18, 2022, the Company consummated the Initial Public Offering of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZPkPxjL82xa" title="Stock issued during period shares new issues">6,600,000</span> units, including <span id="xdx_905_ecustom--AdditionalUnitsIssuedToExercise_pid_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zZvcV3RIdXd8" title="additional units issued to exercise">600,000</span> additional units issued pursuant
to the partial exercise by the underwriter of its over-allotment option, generating gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKn1oq7NwJGi" title="Proceeds from issuance initial public offering">66,000,000</span>, which is described
in Notes 1 and 3.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zT7ybciQOgVe" title="Stock issued during period shares new issues">394,000</span>
nits, to the Sponsor at a price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z7Kz8eI78pK1" title="Shares issued price per share">10.00</span> per private placement unit, generating total proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zjJx3ZkVLMt1" title="Proceeds from issuance initial public offering">3,940,000</span>, which is described in
Notes 1 and 4.</span></p>
6600000
600000
66000000
394000
10.00
3940000